These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14759580)

  • 1. Commercial preparations and handling of botulinum toxin type A and type B.
    Parish JL
    Clin Dermatol; 2003; 21(6):481-4. PubMed ID: 14759580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary: botulinum toxin in clinical medicine.
    Benedetto AV
    Clin Dermatol; 2003; 21(6):465-8. PubMed ID: 14759576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin for rejuvenation of the neck.
    Brandt FS; Boker A
    Clin Dermatol; 2003; 21(6):513-20. PubMed ID: 14759585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin-B and the management of hyperhidrosis.
    Baumann LS; Halem ML
    Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Where has all the botox gone? (how) will we ever learn... using monoclonal antibodies to track botulinum toxin.
    Lim EC; Oh VM; Ong BK; Chow AW; Seet RC
    Med Hypotheses; 2006; 67(3):440-6. PubMed ID: 16678355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periocular botulinum toxin.
    Flynn TC
    Clin Dermatol; 2003; 21(6):498-504. PubMed ID: 14759583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin in the lower one third of the face.
    Atamoros FP
    Clin Dermatol; 2003; 21(6):505-12. PubMed ID: 14759584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of the clinical use of botulinum toxin A and B.
    Carruthers A
    Clin Dermatol; 2003; 21(6):469-72. PubMed ID: 14759577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cosmetic uses of botulinum toxins for lower aspects of the face and neck.
    Lowe NJ; Yamauchi P
    Clin Dermatol; 2004; 22(1):18-22. PubMed ID: 15158540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin for the treatment of headaches: a review of current practices and evidence based-data.
    Ateş Y
    Agri; 2006 Jul; 18(3):5-11. PubMed ID: 17089224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding use of botulinum toxin.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between intramuscular and perimuscular injections of botulinum toxin type A.
    Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM
    Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases.
    Işeri M; Işeri PK
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type A botulinum toxin in the upper aspect of the face.
    Hexsel D; Dal'forno T
    Clin Dermatol; 2003; 21(6):488-97. PubMed ID: 14759582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin: a review of applications for the head and neck.
    Seidman LM; Brooks JK; Bashirelahi N
    Gen Dent; 2019; 67(2):55-58. PubMed ID: 30875307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type B: pH change reduces injection pain, retains efficacy.
    Lowe PL; Lowe NJ
    Dermatol Surg; 2014 Dec; 40(12):1328-33. PubMed ID: 25350125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to avoid complications when treating hyperdynamic folds and wrinkles.
    Sommer B
    Clin Dermatol; 2003; 21(6):521-3. PubMed ID: 14759586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new possibility for focal treatment of spasticity with botulinum neurotoxin. The Danish Society of Neurology].
    Jeppesen LL; Dalager T; Meden P
    Ugeskr Laeger; 2004 Mar; 166(12):1117. PubMed ID: 15067776
    [No Abstract]   [Full Text] [Related]  

  • 19. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
    Alster TS; Lupton JR
    Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin. Development for therapeutic purposes].
    Ceballos-Baumann A
    Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.